Adrenal cortical mitochondrial proteins

Adrenal cortical mitochondrial proteins comprise a group of enzymes and electron-transfer proteins located within the mitochondria of the adrenal cortex, primarily responsible for the biosynthesis of steroid hormones (steroidogenesis) [PMID: 11549668]. Key members of this group include the cytochrome P450 enzymes CYP11A1 (cholesterol side-chain cleavage enzyme), CYP11B1 (11β-hydroxylase), and CYP11B2 (aldosterone synthase), along with their essential electron donors, adrenodoxin and adrenodoxin reductase [PMID: 26447768]. These proteins are critical for the production of glucocorticoids (cortisol), mineralocorticoids (aldosterone), and adrenal androgens from cholesterol. In clinical practice, these proteins are significant targets for drugs like mitotane, which undergoes bioactivation by mitochondrial enzymes to form reactive intermediates that covalently bind to and destroy mitochondrial components, leading to adrenocorticolysis in the treatment of adrenocortical carcinoma [PMID: 24106614]. Additionally, specific enzymes in this group are targeted by inhibitors such as metyrapone and osilodrostat to manage Cushing's syndrome by blocking cortisol synthesis [PMID: 32101514]. They also serve as autoantigens in autoimmune adrenal diseases, where the immune system targets these proteins, leading to primary adrenal insufficiency [PMID: 11549668].

Other names

Adrenal mitochondrial enzymesSteroidogenic mitochondrial proteinsAdrenal mitochondrial fractionMitochondrial steroidogenic enzymes

Drugs targeting these proteins act either by direct enzymatic inhibition of steroidogenic pathways (e.g., metyrapone, osilodrostat) or by serving as substrates for bioactivation into reactive, cytotoxic metabolites that cause irreversible mitochondrial damage and adrenocorticolysis (e.g., mitotane).